More importantly, our study clearly demonstrates a very promising therapeutic potential of cyclin E siRNA for treating the cyclin E-overexpressing breast cancers, including the very malignant triple-negative breast cancers. This evidence concerns the gene CCNE1 and triple-negative breast carcinoma.